Waskyra J Code: J3386
Injection, etuvetidigene autotemcel, per treatment
Drug & Product Overview
About Waskyra
Waskyra is a medication aligned to the HCPCS J Code: J3386 for billing, pricing, and reimbursement purposes in the United States. Classified under Genetic Disorder, it is administered via the intravenous route and manufactured by Fondazione Telethon ETS.
Manufacturers, reach out to us to add more information.
NDC Code Information
No NDC packages are aligned to J3386 in publicly available CMS files.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| No public NDC alignments | ||||
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
Waskyra Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Waskyra billing and coding guide?
Are there any available Waskyra patient assistance programs?
Where can I find Waskyra prescribing information?
Where can I find Waskyra side effect information?
Does billing WASKYRA require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to Waskyra.